Safety, Tolerability and Pharmacokinetics Study of LY03005

Clinical trial NCT02055300 · COMPLETED

Trial details

NCT number: NCT02055300
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2014-02-01
Primary completion: 2014-08-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.